Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S       DK0060102614

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Novo Nordisk B : Novo Nordisk reaches a milestone in animal testing (VIDEO) (28 November 2011)

11/28/2011| 09:11am US/Eastern
Recommend:
0

As of 28 November 2011, Novo Nordisk will no longer use living animals to test the quality of the batches of medicine coming out of Novo Nordisk's production lines. These tests have for years been required by health authorities as part of their approval of the products.

"Today's achievement is a milestone in our ongoing commitment to animal ethics in Novo Nordisk. We have been working for more than a decade, in close collaboration with regulatory authorities around the world, to eliminate obsolete tests or develop and certify new laboratory assays that can be used instead of animals to evaluate the consistent quality of our marketed products," says Executive Vice President and Chief Science Officer, Mads Krogsgaard Thomsen.

Novo Nordisk has a commitment to the 3R principles to 'Reduce', 'Refine' or 'Replace' the use of animal testing within the pharmaceutical industry. Therefore, a task force was established more than ten years ago with the ambitious aim to eliminate all redundant  product control tests in living animals or replace them with other test methods that would guarantee the same product safety.

Live animals that have been used in these biological product control tests include mice, rats, guinea pigs, hamsters and rabbits. Over the years, the number of animals used in this area has been gradually reduced from more than 13,000 animals a year in the 90s, to 2,078 animals in 2000 and to 772 animals in 2010. The last living animals are used for a virus control on 28 November 2011, and in 2012 the number of biological product control tests performed on living animals will be zero.

In the 90s Novo Nordisk reduced the total number of animals used by almost 70%. Since then Novo Nordisk has been able to keep the numbers at approximately the same level despite increasing research activities year on year.

In 2010, the number of animals used in Novo Nordisk was 62,152. At present, some experiments on living animals are essential for all pharmaceutical companies in the processes of discovery and development of new pharmaceuticals. It is in addition a requirement from the authorities that drug candidates are tested in living animals before they can be tested in humans.

See the video "A milestone in animal ethics" (duration 9 mins)

For more information, please contact:
Mette Kruse Danielsen
Media Relations Manager
Tel +45 3079 3883
email: mkd@novonordisk.com

Recommend :
0
Partner Area
React to this article
 
Latest news on NOVO NORDISK A/S
8h agoDJNOVO NORDISK A/S: Novo Nordisk : Liraglutide Leads to Weight Loss in Study
2d agoDJNovo Buys Xellia Pharmaceuticals for $700 Million
05/03 NOVO NORDISK A/S: purchases B shares worth DKK 2.5 billion from Novo A/S as par..
05/03 NOVO NORDISK A/S: køber B-aktier til en værdi af 2,5 mia. kr. fra Novo A/S som ..
05/02 NOVO NORDISK A/S: Trading in Novo Nordisk shares by board members, executives a..
05/02 Sanofi says to step up development of new diabetes device
05/01DJNOVO NORDISK A/S: Novo Nordisk Net Profit Up As Insulin Sales Surge
04/30 NOVO NORDISK A/S: det samlede antal stemmerettigheder og den samlede kapital i ..
04/30 NOVO NORDISK A/S: Total number of voting rights and share capital in Novo Nordi..
04/09DJCorrection to story about diabetes in Mexico
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | DK0060102614 | 4-Traders
Income Statement Evolution
Novo Nordisk A_S : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.